With a market cap of $55.7 billion, Cardinal Health, Inc. (CAH) is a global healthcare services and products company that distributes pharmaceuticals, specialty medications, and medical and laboratory products while providing home-health, direct-to-patient, and nuclear pharmacy services. With a strong customer-centric approach, the company drives continuous innovation and delivers solutions that enhance healthcare efficiency and improve people's lives every day.
Shares of the prescription drug distributor have outperformed the broader market over the past 52 weeks. CAH stock has climbed 55.5% over this time frame, while the broader S&P 500 Index ($SPX) has increased 22.1%. Moreover, the stock has gained 16.1% on a YTD basis, compared to SPX's 13.1% rise.